Skip to main content

Table 1 Clinical features of the study population

From: Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study

 

All(n = 250)

HBV DNA-positive(n = 77)

HBV DNA-negative (n = 173)

P

HBsAg-positive(n = 200)

HBsAg-negative(n = 50)

P

Male sex

183,73.2

63,81.8

120,69.4

0.040

145,72.5

38,76.0

0.617

Age(y)

53.90 ± 11.73

54.13 ± 11.76

53.80 ± 11.75

0.837

53.01 ± 11.35

57.46 ± 11.65

0.016

Hypertension

36,14.4

12,15.6

24,13.9

0.722

25,12.5

11,22.0

0.087

Diabetes

48,19.2

14,18.2

34,19.7

0.785

40,20.0

8,16.0

0.521

CTP

A

38,15.2

8,10.4

30,17.3

0.158

25,12.5

13,26.0

0.017

B/C

212, 84.8

69,89.6

143,82.7

175,87.5

37,74.0

HBeAg-positive

137,54.8

23,29.9

114,65.9

 < 0.001

107,53.5

30,60.0

0.409

HBsAg-positive

200, 80%

70,90.9%

130,75.1

0.004

-

-

-

HBV DNA-positive

-

-

-

-

70,35.0

7,14.0

0.004

MELD

13.17 ± 6.13

13.71 ± 5.89

12.92 ± 6.23

0.348

13.33 ± 6.32

12.52 ± 5.30

0.404

APRI

1.98(1.07, 3.27)

2.58(1.27, 3.57)

1.84(0.95,2.78)

0.005

2.10(1.17,3.27)

1.23(0.66, 2.37)

0.002

FIB-4

6.69(3.86, 9.91)

7.93(4.89, 10.85)

6.14(3.55,9.71)

0.044

7.42(4.45,9.79)

4.59(2.91,10.94)

0.050

TBIL(umol/L)

29.07(19.82,64.74)

30.90(20.94, 57.04)

29.00(16.66, 58.07)

0.301

28.85(17.78, 64.10)

29.71(21.58, 43.52)

0.942

ALB(g/L)

29.75(26.38,34.80)

29.58(26.65, 33.00)

30.19(25.66, 35.10)

0.495

29.58(26.24,34.18)

30.44(26.30,36.73)

0.084

SCr(umol/L)

62.00(51.22,77.00)

65.00(53.50,78.00)

61.00(49.00,74.83)

0.177

61.07(50.10,74.05)

64.38(52.98,81.02)

0.315

ALT(U/L)

33.43(21.65,66.12)

38.74(26.43, 75.73)

31.20(19.91, 56.32)

0.018

35.07(21.97,63.35)

27.95(17.62,45.29)

0.044

AST(U/L)

50.74(32.50,95.80)

62.40(35.49, 96.47)

46.00(30.15, 82.75)

0.071

53.33(35.03,92.50)

36.85(27.09,77.23)

0.051

GGT(U/L)

49.00(25.30,92.57)

55.00(32.73, 99.11)

46.00(23.39, 100.68)

0.214

49.15(26.65,91.09)

42.60(22.10,147.35)

0.765

ALP(U/L)

97.00(72.00,150.30)

109.10(76.60, 154.86)

93.00(70.52, 141.75)

0.108

100.36(76.20,147.65)

80.37(58.98, 156.78)

0.151

INR

1.35(1.15,1.55)

1.37(1.19,1.60)

1.33(1.15,1.58)

0.191

1.37(1.15,1.62)

1.28(1.13,1.45)

0.090

PLT(10^9/L)

68.00(46.00,113.50)

61(42.50,111.50)

72(46.00,123.00)

0.079

67.50(45.00,113.00)

80.50(49.50,139.25)

0.086

  1. Abbreviations: CTP Child-Turcotte-Pugh, MELD Model for end-stage liver disease, APRI AST-to-platelet ratio index, FIB 4 Fibrosis index based on four factors, TBIL Total bilirubin, ALB Albumin, SCr Serum creatinine, ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT Glutamyltransferase, ALP Alkaline phosphatase, INR International normalized ratio, PLT Platelet